FIELD: pharmaceuticals.
SUBSTANCE: new compounds of Formula (I) based on pyrazolopyridinone and pharmaceutical compositions containing these compounds.
(I)
EFFECT: new compounds have been obtained that have inhibitory activity against FGFR (fibroblast growth factor receptor).
24 cl, 2 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS BASED ON PYRAZOLOPYRIDINONE | 2018 |
|
RU2806625C2 |
| NEW QUINOLINE COMPOUNDS | 2018 |
|
RU2810113C2 |
| THIENOPYRIDINONE COMPOUNDS | 2019 |
|
RU2827549C2 |
| NEW COMPOUNDS | 2013 |
|
RU2654857C2 |
| PTERIDINES AS FGFR INHIBITORS | 2013 |
|
RU2702906C2 |
| FGFR INHIBITOR AND ITS APPLICATION | 2018 |
|
RU2745035C1 |
| NEW COMPOUNDS | 2016 |
|
RU2747645C2 |
| IMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASES | 2009 |
|
RU2518089C2 |
| DERIVATIVES OF 1,5- AND 1,7-NAPHTHYRIDINE USEFUL IN TREATMENT OF FGFR-MEDIATED DISEASES | 2012 |
|
RU2629194C2 |
| HETEROCYCLIC IMMUNOMODULATORS AS INHIBITOR OF IMMUNE RESPONSE CHECKPOINTS PDL1 | 2020 |
|
RU2824127C2 |
Authors
Dates
2023-11-07—Published
2018-11-23—Filed